Return on Assets (ROA)
since 2005
Calculation
Cytokinetics Inc., ROA, long-term trends, calculation
| ROA | = | 100 | × | Net income (loss)1 | ÷ | Total assets1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2022 | -38.33% | = | 100 | × | (388,955) | ÷ | 1,014,775) |
| Dec 31, 2021 | -25.59% | = | 100 | × | (215,314) | ÷ | 841,319) |
| Dec 31, 2020 | -23.85% | = | 100 | × | (127,290) | ÷ | 533,803) |
| Dec 31, 2019 | -41.99% | = | 100 | × | (121,692) | ÷ | 289,814) |
| Dec 31, 2018 | -50.33% | = | 100 | × | (106,289) | ÷ | 211,178) |
| Dec 31, 2017 | -43.35% | = | 100 | × | (127,790) | ÷ | 294,810) |
| Dec 31, 2016 | 9.67% | = | 100 | × | 16,453) | ÷ | 170,142) |
| Dec 31, 2015 | -32.54% | = | 100 | × | (37,501) | ÷ | 115,237) |
| Dec 31, 2014 | -11.01% | = | 100 | × | (14,646) | ÷ | 132,968) |
| Dec 31, 2013 | -40.53% | = | 100 | × | (33,717) | ÷ | 83,188) |
| Dec 31, 2012 | -52.06% | = | 100 | × | (40,370) | ÷ | 77,551) |
| Dec 31, 2011 | -90.69% | = | 100 | × | (47,860) | ÷ | 52,773) |
| Dec 31, 2010 | -63.19% | = | 100 | × | (49,287) | ÷ | 77,992) |
| Dec 31, 2009 | 20.02% | = | 100 | × | 24,544) | ÷ | 122,599) |
| Dec 31, 2008 | -64.46% | = | 100 | × | (56,374) | ÷ | 87,454) |
| Dec 31, 2007 | -31.47% | = | 100 | × | (48,894) | ÷ | 155,370) |
| Dec 31, 2006 | -33.69% | = | 100 | × | (57,115) | ÷ | 169,516) |
| Dec 31, 2005 | -46.20% | = | 100 | × | (42,252) | ÷ | 91,461) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
Comparison to Competitors
Cytokinetics Inc., ROA, long-term trends, comparison to competitors
| Cytokinetics Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2022 | -38.33% | 8.53% | 10.06% | 6.53% | 8.55% | 12.62% | 7.27% | 9.57% | 13.30% | 15.91% | 14.85% | 7.15% | 18.30% |
| Dec 31, 2021 | -25.59% | 7.88% | 9.63% | 6.40% | 7.73% | 11.44% | 9.16% | 11.47% | 12.35% | 12.11% | 31.75% | 8.12% | 17.44% |
| Dec 31, 2020 | -23.85% | 3.07% | 11.54% | -7.61% | 4.79% | 13.28% | 0.18% | 8.41% | 7.72% | 6.23% | 20.47% | 9.23% | 23.07% |
| Dec 31, 2019 | -41.99% | 8.84% | 13.13% | 2.65% | 4.85% | 21.17% | 8.74% | 9.59% | 11.66% | 9.72% | 14.29% | 6.33% | 14.15% |
| Dec 31, 2018 | -50.33% | 9.58% | 12.64% | 14.06% | 5.54% | 7.36% | 8.57% | 10.00% | 7.53% | 7.00% | 20.83% | 5.22% | 33.57% |
| Dec 31, 2017 | -43.35% | 7.50% | 2.48% | 3.00% | 5.34% | -0.45% | 6.58% | 0.83% | 2.72% | 12.40% | 13.67% | 3.93% | 7.43% |
| Dec 31, 2016 | 9.67% | 9.01% | 9.95% | 13.22% | 5.64% | 7.05% | 23.70% | 11.71% | 4.11% | 4.20% | 12.84% | 4.40% | -3.87% |
| Dec 31, 2015 | -32.54% | 9.70% | 9.69% | 4.93% | 6.96% | 6.77% | 34.93% | 11.55% | 4.36% | 4.16% | 11.34% | 4.83% | -22.26% |
| Dec 31, 2014 | -11.01% | 6.44% | 7.47% | 5.94% | 7.02% | 6.43% | 34.91% | 12.45% | 12.12% | 5.40% | 8.99% | 4.42% | -31.63% |
| Dec 31, 2013 | -40.53% | 14.14% | 7.68% | 6.64% | 7.77% | 13.29% | 13.67% | 10.42% | 4.17% | 12.78% | 14.38% | 4.00% | -19.19% |
| Dec 31, 2012 | -52.06% | 19.53% | 8.00% | 5.46% | 7.26% | 11.89% | 12.20% | 8.94% | 5.81% | 7.84% | 36.06% | 4.29% | -3.88% |
| Dec 31, 2011 | -90.69% | — | 7.54% | 11.25% | 7.25% | 12.92% | 16.20% | 8.51% | 5.97% | 5.32% | -16.75% | 4.96% | 1.34% |
| Dec 31, 2010 | -63.19% | — | 10.64% | 9.98% | 8.07% | 16.35% | 25.03% | 12.96% | 0.81% | 4.23% | -9.59% | 4.85% | -43.74% |
| Dec 31, 2009 | 20.02% | — | 11.62% | 34.22% | 5.88% | 15.76% | 27.18% | 12.95% | 11.51% | 4.05% | -9.15% | 3.93% | -32.84% |
| Dec 31, 2008 | -64.46% | — | 11.51% | 17.76% | 7.53% | -7.09% | 28.65% | 15.25% | 16.54% | 7.29% | -12.34% | 4.71% | -46.90% |
| Dec 31, 2007 | -31.47% | — | 9.14% | 8.27% | 7.84% | 11.02% | 27.68% | 13.06% | 6.77% | 7.07% | -11.28% | 3.59% | -65.05% |
| Dec 31, 2006 | -33.69% | — | 8.73% | 6.20% | 8.72% | 12.13% | -29.12% | 15.67% | 9.95% | 16.84% | -17.49% | 0.79% | -22.45% |
| Dec 31, 2005 | -46.20% | — | 12.54% | 10.66% | 9.80% | 8.05% | 21.62% | 17.94% | 10.33% | 6.88% | -22.54% | 5.25% | -37.05% |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Cytokinetics Inc., ROA, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Cytokinetics Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2022 | -38.33% | 10.67% |
| Dec 31, 2021 | -25.59% | 10.42% |
| Dec 31, 2020 | -23.85% | 5.45% |
| Dec 31, 2019 | -41.99% | 9.02% |
| Dec 31, 2018 | -50.33% | 8.97% |
| Dec 31, 2017 | -43.35% | 5.28% |
| Dec 31, 2016 | 9.67% | 8.61% |
| Dec 31, 2015 | -32.54% | 8.93% |
| Dec 31, 2014 | -11.01% | 9.45% |
| Dec 31, 2013 | -40.53% | 9.46% |
| Dec 31, 2012 | -52.06% | 8.30% |
| Dec 31, 2011 | -90.69% | 7.30% |
| Dec 31, 2010 | -63.19% | 7.07% |
| Dec 31, 2009 | 20.02% | 10.02% |
| Dec 31, 2008 | -64.46% | 10.37% |
| Dec 31, 2007 | -31.47% | 8.86% |
| Dec 31, 2006 | -33.69% | 11.91% |
| Dec 31, 2005 | -46.20% | 10.42% |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Cytokinetics Inc., ROA, long-term trends, comparison to industry (health care)
| Cytokinetics Inc. | Health Care | |
|---|---|---|
| Dec 31, 2022 | -38.33% | 8.43% |
| Dec 31, 2021 | -25.59% | 8.29% |
| Dec 31, 2020 | -23.85% | 5.45% |
| Dec 31, 2019 | -41.99% | 7.18% |
| Dec 31, 2018 | -50.33% | 6.22% |
| Dec 31, 2017 | -43.35% | 5.24% |
| Dec 31, 2016 | 9.67% | 6.99% |
| Dec 31, 2015 | -32.54% | 7.36% |
| Dec 31, 2014 | -11.01% | 8.16% |
| Dec 31, 2013 | -40.53% | 8.27% |
| Dec 31, 2012 | -52.06% | 7.68% |
| Dec 31, 2011 | -90.69% | 6.96% |
| Dec 31, 2010 | -63.19% | 6.89% |
| Dec 31, 2009 | 20.02% | 9.13% |
| Dec 31, 2008 | -64.46% | 8.55% |
| Dec 31, 2007 | -31.47% | 8.15% |
| Dec 31, 2006 | -33.69% | 9.80% |
| Dec 31, 2005 | -46.20% | 9.10% |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).